Navigation Links
Escherichia coli DH5

Multiporator / Electroporator 2510 Transformation Protocol Protocol No. 4308 915.512 04/2002 Microorganism Escherichia coli DH5alpha Cell type Bacteria, gram negative Molecules injected Plasmid DNA (pUC 19) Growth medium LB medium Washing solution Sterile, ice-cold water; (10% glycerol) Electroporation solution Sterile, ice-cold water; (10% glycerol) Outgrowth medium SOC medium (without antibiotics) Cuvette 1 mm gap width Reference Eppendorf AG Application Hotline D-22331 Hamburg
Phone +49 180 3 666 789 Fax +49 40 53990 125 e-mail: application-hotline@eppendorf.de
Adapted from: High Efficiency Transformation by Electroporation Short Protocols in Molecular Biology
Second Edition Green Publishing Association and John Wiley & Sons, New York 1-22 1-23 Making electrocompetent cells: 1. Inoculate 500 ml LB medium with 2.5 ml of a fresh overnight culture of E. coli DH5alpha. Grow at 37 C with shaking to an O.D.600 of 0.5 to 0.6. 2. Chill cells on ice for 15 minutes a nd transfer to a prechilled centrifuge bottle. Harvest by centrifugation (20 minutes, 5,000 x g, 2-4 C). Resuspend pellet in 5 ml ice-cold water. Keep the cells cold during the entire procedure. 3. Wash twice with the original culture volume of ice-cold water. Centrifuge as above. Resuspend pellet by swirling in remaining liquid. 4a. If using the cells immediately, place suspension in a prechilled tube and centrifuge (10 minutes, 5,000 x g, 2-4 C). Resuspend the cells in ice-cold water to a final concentration of approximately 2 x 1011 cells/ml. Aliquote 40-300 l cells into prechilled centrifuge tubes. 4b. If freezing the cells for later use, add 40 ml of ice-cold 10% glycerol, mix and centrifuge for 10 minutes, at 5,000 x g and 2-4 C. Resuspend the cells in ice-cold 10% glycerol to a final concentration of approximately, 2 x 1011 cells/ml. Aliquote 40-300 l cells into prechilled centrifuge tubes. quick freeze on dry ice and store at 80 C.

Electroporation of cells:

  1. Add 1 l DNA (10 pg in water) to tubes containing 40 l electrocompetent cells. Homogenize by gently mixing with
    pipette several times.
  2. Transfer mixture to a prechilled cuvette. Wipe moisture from the cuvette and insert the cuvette into the device.
  3. Electroporation:

    Mode Prokaryotes O Voltage (V) 1,700 V Time constant (T) 5 ms
  4. Immediately add 1 ml SOC medium and transfer to a sterile culture tube with a pasteur pipette. Incubate 30-
    60 minutes with moderate shaking at 37 C.
  5. Plate on LB plates containing the appropriate selection chemical.
Expected Results: Transformation efficiency up to 3 x 109 transformants/g of DNA.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Escherichia coli C600
2. Escherichia coli DH10B
3. Escherichia coli DH5
4. Escherichia coli K12
5. Escherichia coli C600
6. Escherichia coli K12
7. Escherichia coli DH10B
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... , ... August 08, 2018 , ... ... service was developed and is continually updated by a talented scientific team that ... integrated service provides: , 1. Information on the medical impact of a ...
(Date:8/9/2018)... ... August 08, 2018 , ... Since their establishment in ... and with a team nearly double its’ size from last year, the company is ... OpenSPR turned heads and impressed crowds at a private product launch event during ...
(Date:8/9/2018)... ... August 09, 2018 , ... Rockland Immunochemicals, ... Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, composed a peer-reviewed article ... published online on August 9, 2018 and will be printed in the September ...
(Date:8/7/2018)... ... August 06, 2018 , ... ... companies, announces the placement of Dr. Paul Harney as President, North America at ... growth strategy and enhancing client satisfaction. He was also named to Prescient’s Board ...
Breaking Biology Technology:
(Date:8/2/2018)... ... August 02, 2018 , ... The American College of ... Diagnostics to its Lifestyle Medicine Corporate Roundtable, a group of individuals and organizations ... a sustainable world. , Boston Heart is transforming the treatment of cardiovascular ...
(Date:8/1/2018)... ... August 01, 2018 , ... ... the release of Limfinity® version 7.1. Limfinity® is the software framework that all ... creates new possibilities for both current users and the future of RURO’s laboratory ...
(Date:8/1/2018)... ... August 01, 2018 , ... Visikol CEO Dr. Michael Johnson has ... pharmaceutical company partnerships that Visikol will far exceed its original 2018 revenue projections. ... of digital pathology tools, whole mount imaging techniques and ...
Breaking Biology News(10 mins):